Filing Details

Accession Number:
0001628280-25-027340
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-22 17:20:35
Reporting Period:
2025-05-20
Filing Date:
2025-05-22
Accepted Time:
2025-05-22 17:20:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1793390 Clarissa Desjardins 700 Us Highway 202/206
Bridgewater NJ 08807
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-20 1,895 $66.87 1,895 No 4 P Indirect By spouse
Common Stock Acquisiton 2025-05-21 1,130 $66.35 3,025 No 4 P Indirect By spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By spouse
No 4 P Indirect By spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 67,007 Direct
Footnotes
  1. This is the weighted average purchase price representing 1,895 shares purchased at prices ranging from $66.75 to $66.98 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.